查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球乳腺病變定位市場
市場調查報告書
商品編碼
1270935

2023-2030 年全球乳腺病變定位市場

Global Breast Lesion Localization Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3個工作天內

價格

到 2022 年，全球乳腺病變定位市場規模將達到 4.8 億美元，預測期內（2023-2030 年）的複合年增長率為 7.8%，到 2030 年將達到 8 億美元。預計將達到 12 美元百萬。 由於全球乳腺癌患病率上升，預計全球乳腺病變定位市場在預測期內將出現顯著增長。 及早發現可觸及和不可觸及的乳房病變中的惡性腫瘤，可以有效及時地治療各種乳房異常。 全世界每年診斷出的乳腺癌中有三分之一是微觀的，並且隨著篩查計劃變得更加廣泛和更先進的方式（例如 MRI 檢測臨床上可能的病變），這一水平正在上升。 MRI 是一種安全、準確、非手術的診斷可疑乳腺影像異常的方法，對於製定正確的決策（包括制定治療計劃）至關重要。 預計乳腺癌患病率的增加將提高女性對這種疾病的認識，並有助於市場的增長。 此外，市場上越來越多的篩選和成像技術也有望推動市場增長。

細分市場展望

全球乳腺病變定位市場根據類型和應用進行細分。 根據類型，市場分為電線定位、放射性同位素定位、磁定位、電磁定位和其他定位。 此外，根據應用，市場分為乳房活檢、乳房保護（腫塊切除術）等。 其中，由於全球女性乳腺癌患者人數不斷增加等因素，保乳手術預計在預測期內將佔據很大的市場份額。

乳腺病變定位的全球市場預計將由線材定位細分市場主導。

在乳腺病變定位系統市場，導線定位部分預計在預測期內將出現顯著增長。 這是由於乳腺癌患者增加、技術先進產品增加以及產品發布增加等因素造成的。 此外，基於導線的定位所提供的優勢，例如比其他乳腺病變定位技術更便宜、更準確和更有效，預計將增加在乳腺癌治療中的採用。 預計該因素也將對該細分市場的增長產生積極影響。

區域展望

全球乳腺病變定位市場分為北美（美國、加拿大）、歐洲（意大利、西班牙、德國、法國等）、亞太地區（印度、中國、日本、韓國等）、其他地區World of the World. 它根據區域進一步細分，包括世界區域（中東和非洲，拉丁美洲）。 我們還可以應要求提供特定地區或國家層面的市場分析。 其中，亞太地區正在進行擴大產品組合、業務多元化、降低成本、提高用戶滿意度、提高乳腺病變定位方法可靠性等戰略舉措，預計將佔很大份額。中等市場增長。

北美有望主導全球乳腺病變定位市場

預計在預測期內，北美將佔據顯著的市場份額。 越來越多的乳腺癌患者、強大的醫療基礎設施以及對乳腺癌的認識不斷提高等因素正在推動乳腺病變定位市場的增長。 預計乳腺癌患者的增加將增加對治療乳腺癌的診斷和外科手術的需求，從而促進乳腺病變定位市場的增長。 此外，該地區不斷增加的產品批准預計將增加市場上本地化設備的可用性，從而推動預測期內的市場增長。

市場參與者展望：

全球乳腺病變定位市場的主要參與者包括 Argon Medical Devices、Matek Medical Devices Technology Industry and Trade Inc.、Sterylab S.R.L.、Medax Medical Devices 等。 市場參與者通過採用併購、合作夥伴關係、合作、融資和新產品發布等各種戰略來保持市場競爭力，為市場增長做出了重大貢獻。 例如，2022 年 7 月，Merit Medical System 在一項上市後觀察研究中宣布了首位註冊患者，以證明其無線雷達引導立體定向系統 SCOUT 在標記乳腺腫瘤、活檢部位和淋巴結方面的優勢。

內容

第 1 章報告概述

  • 分析行業現狀和發展前景
  • 研究方法和工具
  • 市場細分
    • 按細分
    • 按地區

第 2 章市場概述和洞察

  • 調查範圍
  • 分析師觀點和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第三章競爭格局

  • 主要公司分析
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • 關鍵策略分析

第四章市場細分

  • 全球乳腺病變定位市場：按類型分類
    • 電線定位
    • 放射性同位素定位
    • 磁性定位
    • 電磁定位
    • 其他本地化
  • 全球乳腺病變定位市場：按預期用途分類
    • 乳房活檢
    • 保乳手術（乳房腫瘤切除術）
    • 其他

第五章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 世界其他地區

第六章公司簡介

  • Argon Medical Devices
  • Becton, Dickinson and Co.
  • Biomedical S.R.L
  • Biopsybell S.R.L.
  • C.R. Bard, Inc.
  • CP Medical
  • Devicor Medical Products Inc.
  • Endomagnetics Ltd.
  • Hologic Inc.
  • IsoAid
  • Leica Biosystems Nussloch GmbH
  • Matek Medical Devices Technology Industry and Trade Inc.
  • MDL SRL
  • Medax Medical Devices
  • Merit Medical Systems, Inc.
  • Mermaid Medical A/S
  • Molli Surgical Inc.
  • Ranfac Corp.
  • Sirius Medical Systems B.V.
  • Sterylab S.R.L.
  • SurgicEye GmbH
  • Tsunami Medical S.R.L.
  • Vigeo S.R.L.
Product Code: OMR2023832

The global breast lesion localization market size was valued at $480 million in 2022, and is projected to reach $812 million by 2030, registering a CAGR of 7.8% during the forecast period (2023-2030). The global breast lesion localization market is expected to witness significant growth during the forecast period due to rising prevalence of breast cancer across the globe. Early detection of the malignancy of palpable and non-palpable breast lesions can result in effective and timely treatment of various breast abnormalities. One-third of breast cancers diagnosed each year globally are subtle, and this level rises as screening programs become more prevalent and more advanced modalities such as MRI detect more clinically potential lesions. It is a safe and accurate non-surgical method for diagnosing suspicious abnormal findings in breast images and is essential for proper decision making, including treatment planning. The rising incidence of breast cancer is creating awareness about the disease among women which is expected to contribute to the growth of the market. Further, the rise in the number of screening and imaging techniques in the market is also expected to propel the market growth.

Segmental Outlook:

The global breast lesion localization market is segmented based on the type and usage. Based on the type, the market is segmented into wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and other localization. Based on the usage, the market is further sub-segmented into breast biopsy, breast conservation (lumpectomy), and others. Among the usage, the breast conservation is expected to hold considerable share in the market over the forecast period owing to factors such as the rising number of breast cancer among the women globally.

The Wire Localization Sub-Segment is anticipated to Hold Prominent Share in the Global Breast Lesion Localization Market

The wire localization segment is expected to witness significant growth in the breast lesion localization systems market over the forecast period owing to factors such as the rising prevalence of breast cancer among the population, growing technologically advanced products, and rising product launches. The advantages offered by the wire localization method, such as being less expensive, more accurate, and more effective than other breast lesion localization techniques, are also expected to increase its adoption during breast cancer treatment. This factor is also expected to impact the growth of the segment positively.

Regional Outlooks:

The global breast lesion localization market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for particular region or country level as per the requirement. Among these, the Asia-Pacific regional market is expected to hold significant share in the market growth over the forecast period owing to the factors such as market players are taking strategic initiatives on widening product portfolio, diversified business operations, lower costs, user satisfaction, and improve breast lesion localization Methods reliability.

The North America Region Is Expected To Hold Prominent Share in the Global Breast Lesion Localization Market

North America is expected to hold a prominent share in the market over the forecast period. The factors such as rising burden of breast cancer cases coupled with robust healthcare infrastructure and increasing awareness about breast cancer are propelling the growth of the breast lesion localization market. The rising breast cancer cases rise the demand for diagnostics and surgical procedures for treating breast cancer which will contribute to the breast lesion localization market over the years. Furthermore, the rising product approvals in the region increase the availability of localization devices in the market which is anticipated to boost market growth over the forecast period.

Market Players Outlook:

The major companies serving the global breast lesion localization market include Argon Medical Devices, Matek Medical Devices Technology Industry and Trade Inc., Sterylab S.R.L., Medax Medical Devices, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2022, Merit Medical System enrolled the first patient in a post-market, observational study to demonstrate the benefits of SCOUT, a wireless, radar-guided localization system for marking breast tumors, biopsy sites, and lymph nodes.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Breast Lesion Localization Market by Type
    • 4.1.1. Wire Localization
    • 4.1.2. Radioisotope Localization
    • 4.1.3. Magnetic Localization
    • 4.1.4. Electromagnetic Localization
    • 4.1.5. Other Localization
  • 4.2. Global Breast Lesion Localization Market by Usage
    • 4.2.1. Breast Biopsy
    • 4.2.2. Breast Conservation (Lumpectomy)
    • 4.2.3. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Argon Medical Devices
  • 6.2. Becton, Dickinson and Co.
  • 6.3. Biomedical S.R.L
  • 6.4. Biopsybell S.R.L.
  • 6.5. C.R. Bard, Inc.
  • 6.6. CP Medical
  • 6.7. Devicor Medical Products Inc.
  • 6.8. Endomagnetics Ltd.
  • 6.9. Hologic Inc.
  • 6.10. IsoAid
  • 6.11. Leica Biosystems Nussloch GmbH
  • 6.12. Matek Medical Devices Technology Industry and Trade Inc.
  • 6.13. MDL SRL
  • 6.14. Medax Medical Devices
  • 6.15. Merit Medical Systems, Inc.
  • 6.16. Mermaid Medical A/S
  • 6.17. Molli Surgical Inc.
  • 6.18. Ranfac Corp.
  • 6.19. Sirius Medical Systems B.V.
  • 6.20. Sterylab S.R.L.
  • 6.21. SurgicEye GmbH
  • 6.22. Tsunami Medical S.R.L.
  • 6.23. Vigeo S.R.L.

LIST OF TABLES

  • 1. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL WIRE BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL RADIOISOTOPE BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MAGNETIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY RE-GION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ELECTROMAGNETIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
  • 8. GLOBAL BREAST BIOPSY LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL BREAST CONSERVATION LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY US-AGE, 2022-2030 ($ MILLION)
  • 15. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY US-AGE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL WIRE BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL RADIOISOTOPE BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MAGNETIC BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ELECTROMAGNETIC BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY USAGE, 2022 VS 2030 (%)
  • 8. GLOBAL BREAST BIOPSY LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL BREAST CONSERVATION LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. US BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. CANADA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. UK BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. FRANCE BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. GERMANY BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. ITALY BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. SPAIN BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. REST OF EUROPE BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. INDIA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. CHINA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. JAPAN BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SOUTH KOREA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)